Bramhecha YM, Guerard KP, Audet-Walsh E, Rouzbeh S, et al. Fatty acid oxidation enzyme Delta3, Delta2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients. Oncogene 2022 Apr 11. pii: 10.1038/s41388-022-02276.
PMID: 35411033